Ulrike Söling

776 total citations
16 papers, 525 citations indexed

About

Ulrike Söling is a scholar working on Oncology, Genetics and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ulrike Söling has authored 16 papers receiving a total of 525 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 6 papers in Genetics and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ulrike Söling's work include Cancer Treatment and Pharmacology (6 papers), Advanced Breast Cancer Therapies (5 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Ulrike Söling is often cited by papers focused on Cancer Treatment and Pharmacology (6 papers), Advanced Breast Cancer Therapies (5 papers) and Chronic Lymphocytic Leukemia Research (5 papers). Ulrike Söling collaborates with scholars based in Germany, Austria and United States. Ulrike Söling's co-authors include Stephan Stilgenbauer, Raymonde Busch, Michael Hallek, Hartmut Döhner, Ulrich Jäger, Thorsten Zenz, Manfred Hensel, Jürgen Finke, Eva Lengfelder and Rudolf Schlag and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Ulrike Söling

15 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ulrike Söling Germany 8 447 380 201 126 83 16 525
Bertrand Anz United States 7 472 1.1× 391 1.0× 168 0.8× 171 1.4× 79 1.0× 20 543
Владимир Стругов Russia 4 466 1.0× 392 1.0× 167 0.8× 124 1.0× 74 0.9× 12 485
Ghayathri Jeyakumar United States 4 283 0.6× 253 0.7× 125 0.6× 89 0.7× 81 1.0× 9 388
Andrzej Pluta Poland 8 380 0.9× 295 0.8× 116 0.6× 186 1.5× 62 0.7× 23 519
Polina Kaplan Poland 6 283 0.6× 228 0.6× 94 0.5× 116 0.9× 39 0.5× 9 331
Sandra Dai United States 6 713 1.6× 575 1.5× 242 1.2× 189 1.5× 96 1.2× 11 747
Aileen Cohen United States 11 269 0.6× 244 0.6× 76 0.4× 125 1.0× 37 0.4× 30 366
Laura Wake United States 5 221 0.5× 186 0.5× 102 0.5× 51 0.4× 26 0.3× 17 270
Elizabeth Bilotti United States 12 584 1.3× 460 1.2× 206 1.0× 385 3.1× 58 0.7× 29 832
Lucia Morello Italy 8 324 0.7× 316 0.8× 145 0.7× 77 0.6× 12 0.1× 15 443

Countries citing papers authored by Ulrike Söling

Since Specialization
Citations

This map shows the geographic impact of Ulrike Söling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ulrike Söling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ulrike Söling more than expected).

Fields of papers citing papers by Ulrike Söling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ulrike Söling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ulrike Söling. The network helps show where Ulrike Söling may publish in the future.

Co-authorship network of co-authors of Ulrike Söling

This figure shows the co-authorship network connecting the top 25 collaborators of Ulrike Söling. A scholar is included among the top collaborators of Ulrike Söling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ulrike Söling. Ulrike Söling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Söling, Ulrike, et al.. (2022). Significance of Patient-Reported Outcomes for Metastatic Breast Cancer Patients. Oncology Research and Treatment. 45(7-8). 423–429. 7 indexed citations
2.
3.
4.
5.
Marschner, Norbert, Christoph Salat, Ulrike Söling, et al.. (2018). Final Effectiveness and Safety Results of NABUCCO: Real-World Data From a Noninterventional, Prospective, Multicenter Study in 697 Patients With Metastatic Breast Cancer Treated With nab-Paclitaxel. Clinical Breast Cancer. 18(6). e1323–e1337. 12 indexed citations
6.
Potthoff, Karin, Arnd Nusch, Ulrike Söling, et al.. (2016). Efficacy and safety of nab-paclitaxel in patients with metastatic breast cancer: final results of the non-interventional study NABUCCO. Annals of Oncology. 27. vi72–vi72.
7.
Hagenbeck, Carsten, Bürkard Jäger, Helmut Forstbauer, et al.. (2013). Prognostische Relevanz des HER2/neu Status für das Überleben von Brustkrebspatientinnen. Senologie - Zeitschrift für Mammadiagnostik und -therapie. 10(2). 1 indexed citations
8.
Ganster, Christina, Friederike Braulke, Katayoon Shirneshan, et al.. (2011). Proof of Y-Loss As Clonal Abnormality in MDS by Comparative Analysis of CD34+ and CD3+ Peripheral Blood Cells,. Blood. 118(21). 3800–3800. 2 indexed citations
9.
Steinmetz, T., Uwe Totzke, Michael Schweigert, et al.. (2010). A prospective observational study of anaemia management in cancer patients - results from the German Cancer Anaemia Registry. European Journal of Cancer Care. 20(4). 493–502. 20 indexed citations
10.
Eichhorst, Barbara, Raymonde Busch, Stephan Stilgenbauer, et al.. (2009). First-line therapy with fludarabine compared with chlorambucil does not result in a major benefit for elderly patients with advanced chronic lymphocytic leukemia. Blood. 114(16). 3382–3391. 238 indexed citations
11.
Stilgenbauer, Stephan, Thorsten Zenz, Dirk Winkler, et al.. (2009). Subcutaneous Alemtuzumab in Fludarabine-Refractory Chronic Lymphocytic Leukemia: Clinical Results and Prognostic Marker Analyses From the CLL2H Study of the German Chronic Lymphocytic Leukemia Study Group. Journal of Clinical Oncology. 27(24). 3994–4001. 199 indexed citations
12.
Hepp, Philip, Brigitte Rack, Achim Schneider, et al.. (2009). Effects of G-CSF on circulating tumor cells (CTC) and CA 27.29 in breast cancer patients. Journal of Clinical Oncology. 27(15_suppl). 11027–11027. 3 indexed citations
13.
Jackisch, C, Axel Hinke, Winfried Schoenegg, et al.. (2009). Trastuzumab treatment in elderly patients with advanced breast cancer (ABC) – results from a large observational study.. Cancer Research. 69(2_Supplement). 3144–3144. 1 indexed citations
14.
Stilgenbauer, Stephan, Thorsten Zenz, Dirk Winkler, et al.. (2008). Subcutaneous Alemtuzumab (Campath) in Fludarabine-Refractory CLL: Final Results of the CLL2H Trial of the GCLLSG and Comprehensive Analysis of Prognostic Markers. Blood. 112(11). 329–329. 10 indexed citations
15.
Steinmetz, T., Uwe Totzke, Ulrike Söling, et al.. (2008). Hemoglobin levels that trigger erythropoiesis-stimulating agent treatment decisions for cancer-associated anemia – examination of practice in Germany. Current Medical Research and Opinion. 24(10). 2751–2756. 10 indexed citations
16.
Stilgenbauer, Stephan, Dirk Winkler, Andreas Bühler, et al.. (2007). Subcutaneous Alemtuzumab (MabCampath) in Fludarabine-Refractory CLL (CLL2H Trial of the GCLLSG).. Blood. 110(11). 3120–3120. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bertrand Anz Breakdown of academic impact, for papers by Владимир Стругов Breakdown of academic impact, for papers by Ghayathri Jeyakumar Breakdown of academic impact, for papers by Andrzej Pluta Breakdown of academic impact, for papers by Polina Kaplan Breakdown of academic impact, for papers by Sandra Dai Breakdown of academic impact, for papers by Aileen Cohen Breakdown of academic impact, for papers by Laura Wake Breakdown of academic impact, for papers by Elizabeth Bilotti Breakdown of academic impact, for papers by Lucia Morello
Rankless by CCL
2026